Our findings demonstrate that USP5 overexpression in MSCs contributes to the aberrant proliferation observed in MPN by modulating the apoptosis pathway, specifically through the regulation of Caspase-3. The gene discussed is USP5; the disease is myeloproliferative neoplasm.